Principal Statistician - Oncology Statistics

Join our industry-leading Statistics team, dedicated to embedding high-quality quantitative reasoning at the heart of every project in our portfolio. At GSK, statisticians are essential in maximizing the use of all available data points to efficiently develop translational strategies that underpin our comprehensive clinical development plans.

The Oncology Clinical Development Statistics group is seeking exceptionally talented and dedicated Statisticians. In this role, you will apply your statistical expertise and innovative methodologies to make key contributions to the development of new medicines in the Oncology field. You will provide statistical and strategic insights into clinical development plans and the design of end-to-end development strategies, from early first-in-human trials to late-phase drug development. Our team is committed to utilizing novel clinical trial designs and innovative statistical methods, including Bayesian techniques, to assess risk as well as probability of success for both studies and overall programs to enable informed decision-making.

Despite the listing of GSK-Upper Providence as the primary job location, candidates will be considered equally from the Upper Providence (USA), Waltham (USA), GSK HQ – London (UK) and Stevenage (UK) sites. 2-3 days per week on site.

Key Responsibilities:

• Provide required statistical support to Project and Study Statisticians across the oncology team

• Provide statistical input to the design, analysis, reporting and interpretation of clinical studies using a wide range of statistical approaches and/or applicable software (e.g. simulation, Bayesian methods, interim analysis strategies).

• Author statistical analysis plans and prepare statistical input to key documents (including protocol) and presentation material

• Apply standard processes to tasks to ensure that deliverables are accurate, high quality and meet agreed timelines

• Build and maintain effective strategic working relationships with internal and external partners to meet business needs

• Identify, develop, and implement novel statistical methodologies in support of medicines development

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• MS in Statistics or related discipline with 3+ years of relevant experience

• Experience working as a Statistician in the Pharmaceutical Industry

• Experience implementing innovative method by simulation using R, SAS or other software

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• PhD in Statistics or closely related field

• Practical understanding of Statistical Modelling and its application to Real World clinical problems

• Experience with Bayesian methods

• Expertise and practical application in multiple statistical methodologies

• Capable of applying innovative statistical thinking

• Track record of strong performance in an industry or academic setting

• Excellent interpersonal and communication skills

• Capability in building and maintaining strong working relationships in a team setting

• Demonstrated ability to explain novel and standard methods to scientific and clinical colleagues

• Strong influencing skills applied effectively across functions and levels of an organization

• Self-motivated and independent worker

• Strong time management skills; able to effectively organize and manage a variety of tasks across different projects

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HI